Related references
Note: Only part of the references are listed.Radiofrequency Ablation for Renal Cancer in Von Hippel-Lindau Syndrome Patients: A Prospective Cohort Analysis
Marco Allasia et al.
CLINICAL GENITOURINARY CANCER (2018)
Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma
James J. Hsieh et al.
EUROPEAN UROLOGY (2017)
Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial
Toni K. Choueiri et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Combined mutation in Vhl, Trp53 and Rb1 causes clear cell renal cell carcinoma in mice
Sabine Harlander et al.
NATURE MEDICINE (2017)
Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade
Yi-Feng Gu et al.
CANCER DISCOVERY (2017)
The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma
Amrita M. Nargund et al.
CELL REPORTS (2017)
Effectiveness and safety of computed tomography-guided radiofrequency ablation of renal cancer: a 14-year single institution experience in 203 patients
Jason D. Iannuccilli et al.
EUROPEAN RADIOLOGY (2016)
Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma
David J. Kwiatkowski et al.
CLINICAL CANCER RESEARCH (2016)
Loss of vhl in the zebrafish pronephros recapitulates early stages of human clear cell renal cell carcinoma
Haley R. Noonan et al.
DISEASE MODELS & MECHANISMS (2016)
Microwave treatment of renal cell carcinoma adjacent to renal sinus
Yongyan Gao et al.
EUROPEAN JOURNAL OF RADIOLOGY (2016)
Independent assessment of lenvatinib plus everolimus in patients with metastatic renal cell carcinoma
Robert J. Motzer et al.
LANCET ONCOLOGY (2016)
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
Toni K. Choueiri et al.
LANCET ONCOLOGY (2016)
Targeting renal cell carcinoma with a HIF-2 antagonist
Wenfang Chen et al.
NATURE (2016)
On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models
Hyejin Cho et al.
NATURE (2016)
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy
A. Ravaud et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose-response relationship
Shankar Siva et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Patient-specific factors influence somatic variation patterns in von Hippel-Lindau disease renal tumours
Suzanne S. Fei et al.
NATURE COMMUNICATIONS (2016)
Midterm results of percutaneous microwave ablation under ultrasound guidance versus retroperitoneal laparoscopic radial nephrectomy for small renal cell carcinoma
Jie Yu et al.
ABDOMINAL IMAGING (2015)
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
Borje Ljungberg et al.
EUROPEAN UROLOGY (2015)
Single Fraction Radiosurgery for the Treatment of Renal Tumors
Michael Staehler et al.
JOURNAL OF UROLOGY (2015)
CT-Guided Percutaneous Cryoablation in Renal Cell Carcinoma: Factors Affecting Local Tumor Control
Takashi Yamanaka et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2015)
Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
Robert J. Motzer et al.
LANCET ONCOLOGY (2015)
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Christina Twyman-Saint Victor et al.
NATURE (2015)
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma
T. K. Choueiri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Renal cryoablation of small renal masses: A Korea University experience
Hyung Keun Kim et al.
KOREAN JOURNAL OF UROLOGY (2015)
Efficacy and Safety of Percutaneous Cryoablation for Stage 1A/B Renal Cell Carcinoma: Results of a Prospective, Single-Arm, 5-Year Study
Christos S. Georgiades et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2014)
High-Powered Microwave Ablation of T1a Renal Cell Carcinoma: Safety and Initial Clinical Evaluation
Anna J. Moreland et al.
JOURNAL OF ENDOUROLOGY (2014)
Radiotherapy for renal-cell carcinoma
Gert De Meerleer et al.
LANCET ONCOLOGY (2014)
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
Marco Gerlinger et al.
NATURE GENETICS (2014)
Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution
Rosalie Fisher et al.
GENOME BIOLOGY (2014)
Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease: indications, techniques, complications, and outcomes
Byung Kwan Park et al.
ACTA RADIOLOGICA (2013)
Percutaneous cryoablation of renal tumours: outcomes from 171 tumours in 147 patients
David J. Breen et al.
BJU INTERNATIONAL (2013)
Activation of HIF2 alpha in Kidney Proximal Tubule Cells Causes Abnormal Glycogen Deposition but not Tumorigenesis
Leiping Fu et al.
CANCER RESEARCH (2013)
Clinical and Pathologic Impact of Select Chromatin-modulating Tumor Suppressors in Clear Cell Renal Cell Carcinoma
A. Ari Hakimi et al.
EUROPEAN UROLOGY (2013)
Long-Term Oncologic Outcomes After Radiofrequency Ablation for T1 Renal Cell Carcinoma
Sarah P. Psutka et al.
EUROPEAN UROLOGY (2013)
Renal Cryoablation Versus Robot-Assisted Partial Nephrectomy: Washington University Long-Term Experience
Youssef S. Tanagho et al.
JOURNAL OF ENDOUROLOGY (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Integrated molecular analysis of clear-cell renal cell carcinoma
Yusuke Sato et al.
NATURE GENETICS (2013)
Role of contrast-enhanced ultrasound in evaluating the efficiency of ultrasound guided percutaneous microwave ablation in patients with renal cell carcinoma
Xin Li et al.
RADIOLOGY AND ONCOLOGY (2013)
Zebrafish xenografts as a tool for in vivo studies on human cancer
Martina Konantz et al.
HEMATOPOIETIC STEM CELLS VIII (2012)
A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma
Shankar Siva et al.
BJU INTERNATIONAL (2012)
Radiofrequency Ablation Versus Partial Nephrectomy in Patients with Solitary Clinical T1a Renal Cell Carcinoma: Comparable Oncologic Outcomes at a Minimum of 5 Years of Follow-Up
Ephrem O. Olweny et al.
EUROPEAN UROLOGY (2012)
Nephron sparing surgery in von Hippel-Lindau associated renal cell carcinoma; clinicopathological long-term follow-up
C. A. Jilg et al.
FAMILIAL CANCER (2012)
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma
Guangwu Guo et al.
NATURE GENETICS (2012)
BAP1 loss defines a new class of renal cell carcinoma
Samuel Pena-LlopiS et al.
NATURE GENETICS (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Growth Kinetics in Von Hippel-Lindau-Associated Renal Cell Carcinoma
C. A. Jilg et al.
UROLOGIA INTERNATIONALIS (2012)
Generation of a Mouse Model of Von Hippel-Lindau Kidney Disease Leading to Renal Cancers by Expression of a Constitutively Active Mutant of HIF1α
Leiping Fu et al.
CANCER RESEARCH (2011)
Progress in Nephron Sparing Therapy for Renal Cell Carcinoma and von Hippel-Lindau Disease
Dominique Joly et al.
JOURNAL OF UROLOGY (2011)
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
Brian I. Rini et al.
LANCET (2011)
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
Ignacio Varela et al.
NATURE (2011)
Long-term Outcomes After Percutaneous Radiofrequency Ablation for Renal Cell Carcinoma
Ronald J. Zagoria et al.
UROLOGY (2011)
Initial Experience Using Microwave Ablation Therapy for Renal Tumor Treatment: 18-Month Follow-up
Scott M. Castle et al.
UROLOGY (2011)
Phase 3 Trial of Everolimus for Metastatic Renal Cell Carcinoma Final Results and Analysis of Prognostic Factors
Robert J. Motzer et al.
CANCER (2010)
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
Cora N. Sternberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Efficacy of Laparoscopic Renal Cryoablation as an Alternative Treatment for Small Renal Mass in Patients with Poor Operability: Experience from the Korean Single Center
Young Hwii Ko et al.
JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES (2010)
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Gillian L. Dalgliesh et al.
NATURE (2010)
Stereotactic body radiation therapy: a novel treatment modality
Simon S. Lo et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Prospective evaluation of radiosurgery for hemangioblastomas in von Hippel-Lindau disease
Ashok R. Asthagiri et al.
NEURO-ONCOLOGY (2010)
Laparoscopic Cryoablation of Renal Masses: Which Lesions Fail?
Timothy R. Yoost et al.
UROLOGY (2010)
ZUR FRAGE DER ANGIOMATOSIS RETINae UND IHRER HIRNKOMPLIKATIONEN
ARVID LINDAU
ACTA OPHTHALMOLOGICA (2009)
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
Gijs van Haaften et al.
NATURE GENETICS (2009)
Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney
Christer Svedman et al.
ACTA ONCOLOGICA (2008)
Patterns of intervention for renal lesions in von Hippel-Lindau disease
Surena F. Matin et al.
BJU INTERNATIONAL (2008)
Feasibility and outcomes of repeat partial nephrectomy
Surena F. Matin
JOURNAL OF ENDOUROLOGY (2008)
Catch of the day: zebrafish as a human cancer model
K. Stoletov et al.
ONCOGENE (2008)
Feasibility and outcomes of repeat partial nephrectomy
Aaron Johnson et al.
JOURNAL OF UROLOGY (2008)
Local recurrence after nephron-sparing surgery in von Hippel-Lindau disease
Guillaume Ploussard et al.
UROLOGY (2007)
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
Gary Hudes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis
Michael V. Rocco et al.
ANNALS OF INTERNAL MEDICINE (2006)
Rend cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor
EB Rankin et al.
CANCER RESEARCH (2006)
Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma
PJ Wersäll et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
AS Go et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Definitive, high-dose-per-fraction, conformal, stereotactic external radiation for renal cell carcinoma
JJ Beitler et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2004)
The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease
BG Duffey et al.
JOURNAL OF UROLOGY (2004)
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer
JC Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Nephron sparing surgery for renal cell carcinoma and von Hippel-Lindau's disease: A single center experience
M Roupret et al.
JOURNAL OF UROLOGY (2003)
HIF activation identifies early lesions in VHL kidneys: Evidence for site-specific tumor suppressor function in the nephron
SJ Mandriota et al.
CANCER CELL (2002)
von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF
MA Hoffman et al.
HUMAN MOLECULAR GENETICS (2001)
Contrasting effects on HIF-1α regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease
SC Clifford et al.
HUMAN MOLECULAR GENETICS (2001)
Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products
AR Schoenfeld et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Thermal ablation therapy for focal malignancy: A unified approach to underlying principles, techniques, and diagnostic imaging guidance
SN Goldberg et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2000)
Share Paper
